-
FROM SCREENING TO VALUE: OUTCOME-BASED EVALUATION IN GULF COOPERATION COUNCIL NCD POLICY FRAMEWORKS
Aug 11, 2026, 17:16 PM -
ASSESSING CROSS-COUNTRY AGREEMENT IN HTA RATINGS: THE CASE OF PORTUGAL AND FRANCE
Aug 11, 2026, 17:16 PM -
AN ECONOMIC EVALUATION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) IMMUNISATION FOR INFANTS IN IRELAND
Aug 11, 2026, 17:16 PM -
BEST PRACTICES DO NOT SCALE EQUALLY: IMPLEMENTATION PRECONDITIONS IN CARDIOVASCULAR CARE ACROSS 15 EUROPEAN SYSTEMS
Aug 11, 2026, 17:16 PM -
REAL-WORLD IMPACT OF CT-DERIVED FRACTIONAL FLOW RESERVE IN A CTCA-FIRST PATHWAY IN SCOTLAND
Aug 11, 2026, 17:16 PM -
IS SYSTEMATIC OBSTRUCTIVE SLEEP APNEA SCREENING COST-EFFECTIVE AFTER ATRIAL FIBRILLATION ABLATION? A TRIAL-BASED ECONOMIC EVALUATION FROM THE SAAFIR RANDOMIZED TRIAL
Aug 11, 2026, 17:16 PM -
EXPLORING BARRIERS TO SHARED DECISION-MAKING (SDM) IN RARE DISEASES FROM THE PHYSICIAN PERSPECTIVE IN EUROPE: FINDINGS FROM A CROSS-SECTIONAL SURVEY
Aug 11, 2026, 17:16 PM -
UPTAKE OF FLT3 INHIBITORS AND IMPACT ON OVERALL SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN SWEDEN
Aug 11, 2026, 17:16 PM -
THE ECONOMIC BURDEN OF EARLY-STAGE HR+/HER2- BREAST CANCER (BC) IN SPAIN: A COST-OF-ILLNESS STUDY
Aug 11, 2026, 17:16 PM -
EMA VS FDA APPROVALS OF INNOVATIVE MEDICINES: A SYSTEMATIC ANALYSIS OF APPROVAL EXCLUSIVITY, APPROVAL SEQUENCING, REGULATORY TIMELINES (2021-2026)
Aug 11, 2026, 17:16 PM -
SURVIVAL CURVE RECONSTRUCTION AS A VALIDATED FRAMEWORK FOR MODEL-BASED COST-UTILITY ANALYSIS IN HTA: A REPRODUCIBLE APPROACH USING PUBLICLY AVAILABLE TRIAL DATA
Aug 11, 2026, 17:16 PM -
A SCENARIO-BASED ASSESSMENT OF THE EFFECTS OF PROPOSED US INTERNATIONAL REFERENCE PRICING MODELS FOR MEDICARE AND MEDICAID
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH RARE MOLD INFECTIONS: EQ-5D-5L RESULTS FROM A PHASE IIB TRIAL EVALUATING OLOROFIM IN ADULTS WITH INVASIVE FUNGAL INFECTIONS AND LIMITED OR NO TREATMENT OPTIONS
Aug 11, 2026, 17:16 PM -
ESTIMATION OF THE ECONOMIC BURDEN IN TRAINING HOSPITAL PERSONNEL FOR INTRAUTERINE DEVICE APPLICATION USING A MONTE CARLO MATHEMATICAL MODEL
Aug 11, 2026, 17:16 PM -
GLOBAL LANDSCAPE OF FISCAL HEALTH MODELING FOR IMMUNIZATION: A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
INDIRECT TREATMENT COMPARISONS IN BREAST CANCER: METHODS AND ACCEPTANCE IN NICE SUBMISSIONS
Aug 11, 2026, 17:16 PM -
TARGETED LITERATURE REVIEW OF DIAGNOSIS, SCREENING AND HEALTH-ECONOMIC MODELS OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF RAPID WHOLE-GENOME SEQUENCING FOR CRITICALLY ILL PEDIATRIC PATIENTS WITH RARE UNDIAGNOSED GENETIC DISEASES IN THE UNITED ARAB EMIRATES
Aug 11, 2026, 17:16 PM -
REAL-TERMS DEPRECIATION OF WILLINGNESS-TO-PAY THRESHOLDS FOR DOUBLE-BRANDED ONCOLOGY COMBINATIONS ACROSS HTA MARKETS, 2015-2025
Aug 11, 2026, 17:16 PM -
HEALTH STATE UTILITY VALUE COMBINATION IN NICE RARE DISEASE APPRAISALS: COMMON PRACTICE OR METHODOLOGICAL GAP?
Aug 11, 2026, 17:16 PM
